On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.

On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.